Logo
homeHome
toggle_offCompany ProfilegroupsBoards & Staffsworkspace_premiumMemberships & PartnersschoolAcademy of Journalismperson_addCareerslinkBlog(EN)emailContact Us
list_altOur JournalslightbulbInstruction for AuthorsbookmarkBrieflands PolicieshandshakePublish My Researchplay_circleJournal Management Systemcredit_cardArticle Processing Chargeszoom_inOpen Peer ReviewimagePublishing Services
menu_bookPublish My Book
  1. Brieflands
  2. journals
  3. Journal of Advanced Immunopharmacology
  4. Articles

  5. Monoclonal Antibodies (mAbs) Approved for Cancer Treatment in the 2020s
  6. Scopus by Title (Ref)

Journal of Advanced Immunopharmacology

homeHome
play_arrowCurrent IssuelistArchiveformat_indent_increaseIn Presscheck_circleAccepted ManuscriptssearchSearch
helpInstruction
infoJournal InformationgroupsBoards and EditorsshareIndexing and Listing Sourcesbar_chartJournal Metricszoom_inOpen Peer Review (OPR)balancePublication Ethics and Malpractice Statementassignment_indReviewer and AE Registration FormcampaignAnnouncement: New Journal TitleemailSupportphoneContact Us
Authors GuideSubmit Manuscript

Scopus by Title (Ref)


1. Innovative methodology for flexible monitoring of various bioprocesses by using pre-existing Raman data coupled with automated transfer learning technique

- Schini A. , et al.

2. Evaluating the immune effector functions induced by humanized anti-CD99 antibody in eliminating T lymphoblastic leukemia/lymphoma cells

- Kotemul K. , et al.

3. Transcriptome Analysis Reveals the Induction of Apoptosis-Related Genes by a Monoclonal Antibody against a New Epitope of CD99 on T-Acute Lymphoblastic Leukemia

- Takheaw N. , et al.

4. CD99 tumor associated antigen is a potential target for antibody therapy of T-cell acute lymphoblastic leukemia

- Kotemul K. , et al.

5. Current Strategy of Monoclonal Antibody: Development, Cloning, Formulation and Drug Delivery

- Kaliyaperumal R. , et al.

6. The diverse landscape of dermatologic toxicities of non-immune checkpoint inhibitor monoclonal antibody-based cancer therapy

- Seervai R.N.H. , et al.

7. Delivery of Drugs into Cancer Cells Using Antibody–Drug Conjugates Based on Receptor-Mediated Endocytosis and the Enhanced Permeability and Retention Effect

- Tashima T. , et al.

HomeInstruction

Articles

  • Current Issue
  • Archive
  • In Press
  • Accepted Manuscripts
  • Search

About Journal

  • Journal Information
  • Boards and Editors
  • Indexing and Listing Sources
  • Journal Metrics
  • Open Peer Review (OPR)
  • Publication Ethics and Malpractice Statement
  • Reviewer and AE Registration Form
  • Announcement: New Journal Title
  • Support
  • Contact Us
Support
Submit a Ticket
BrieflandsBrieflands

Science, Technical, Medical Publisher, Since 2007

All rights reserved by Brieflands, 2026.

Powered by Neoscriber.